Antithrombotic Therapy in Patients With Atrial Fibrillation Treated With Oral Anticoagulation Undergoing Percutaneous Coronary Intervention

Heart Disease and Stroke Statistics—2020 Update: A Report From the American Heart Association

(2020) Salim S. Virani et al.   CIRCULATION

Polymer-based or Polymer-free Stents in Patients at High Bleeding Risk

(2020) Stephan Windecker et al.   NEW ENGLAND JOURNAL OF MEDICINE

Optimal Antithrombotic Regimens for Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention

(2020) Renato D. Lopes et al.   JAMA Cardiology

Risk/Benefit Tradeoff of Antithrombotic Therapy in Patients With Atrial Fibrillation Early and Late After an Acute Coronary Syndrome or Percutaneous Coronary Intervention

(2020) John H. Alexander et al.   CIRCULATION

Effect of Lesion Complexity and Clinical Risk Factors on the Efficacy and Safety of Dabigatran Dual Therapy Versus Warfarin Triple Therapy in Atrial Fibrillation After Percutaneous Coronary Intervention

(2020) Natalia C. Berry et al.   Circulation-Cardiovascular Interventions

Ticagrelor With Aspirin or Alone After Complex PCI: The TWILIGHT-COMPLEX Analysis

(2020) George Dangas et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Validation of the Academic Research Consortium High Bleeding Risk Definition in Contemporary PCI Patients

(2020) Davide Cao et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Label Adherence of Direct Oral Anticoagulants Dosing and Clinical Outcomes in Patients With Atrial Fibrillation

(2020) Hee Tae Yu et al.   Journal of the American Heart Association

Safety and Efficacy of Double Antithrombotic Therapy With Non–Vitamin K Antagonist Oral Anticoagulants in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention: A Systematic Review and Meta‐Analysis

(2020) Davide Capodanno et al.   Journal of the American Heart Association

Pharmacodynamic and Pharmacokinetic Effects of a Low Maintenance Dose Ticagrelor Regimen Versus Standard Dose Clopidogrel in Diabetes Mellitus Patients Without Previous Major Cardiovascular Events Undergoing Elective Percutaneous Coronary Intervention

(2020) Francesco Franchi et al.   CIRCULATION

Edoxaban in atrial fibrillation patients with percutaneous coronary intervention by acute or chronic coronary syndrome presentation: a pre-specified analysis of the ENTRUST-AF PCI trial

(2020) Pascal Vranckx et al.   EUROPEAN HEART JOURNAL

Validation of the Academic Research Consortium for High Bleeding Risk (ARC-HBR) criteria in patients undergoing percutaneous coronary intervention and comparison with contemporary bleeding risk scores

(2020) Yasushi Ueki et al.   EuroIntervention

Antithrombotic Therapy after Acute Coronary Syndrome or PCI in Atrial Fibrillation

(2019) Renato D. Lopes et al.   NEW ENGLAND JOURNAL OF MEDICINE

Dual Antiplatelet Therapy Duration Based on Ischemic and Bleeding Risks After Coronary Stenting

(2019) Francesco Costa et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Dabigatran dual therapy with ticagrelor or clopidogrel after percutaneous coronary intervention in atrial fibrillation patients with or without acute coronary syndrome: a subgroup analysis from the RE-DUAL PCI trial

(2019) Jonas Oldgren et al.   EUROPEAN HEART JOURNAL

Open-Label Randomized Trial Comparing Oral Anticoagulation With and Without Single Antiplatelet Therapy in Patients With Atrial Fibrillation and Stable Coronary Artery Disease Beyond 1 Year After Coronary Stent Implantation

(2019) Yukiko Matsumura-Nakano et al.   CIRCULATION

2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation

(2019) Craig T. January et al.   CIRCULATION

Atrial fibrillation, with ACS and PCI: walking a tightrope

(2019) Roxana Mehran et al.   EUROPEAN HEART JOURNAL

Defining High Bleeding Risk in Patients Undergoing Percutaneous Coronary Intervention

(2019) Philip Urban et al.   CIRCULATION

Updated Expert Consensus Statement on Platelet Function and Genetic Testing for Guiding P2Y12 Receptor Inhibitor Treatment in Percutaneous Coronary Intervention

(2019) Dirk Sibbing et al.   JACC-Cardiovascular Interventions

Management of Antithrombotic Therapy in Atrial Fibrillation Patients Undergoing PCI

(2019) Davide Capodanno et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Safety and Efficacy of Antithrombotic Strategies in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention

(2019) Renato D. Lopes et al.   JAMA Cardiology

Antithrombotic Therapy in Patients with Atrial Fibrillation and Acute Coronary Syndrome Treated Medically or with Percutaneous Coronary Intervention or Undergoing Elective Percutaneous Coronary Intervention: Insights from the AUGUSTUS Trial

(2019) Stephan Windecker et al.   CIRCULATION

2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes

(2019) Juhani Knuuti et al.   EUROPEAN HEART JOURNAL

Dual antithrombotic therapy for atrial fibrillation and PCI

(2019) Davide Capodanno et al.   LANCET

Edoxaban-based versus vitamin K antagonist-based antithrombotic regimen after successful coronary stenting in patients with atrial fibrillation (ENTRUST-AF PCI): a randomised, open-label, phase 3b trial

(2019) Pascal Vranckx et al.   LANCET

Antithrombotic Therapy for Atrial Fibrillation with Stable Coronary Disease

(2019) Satoshi Yasuda et al.   NEW ENGLAND JOURNAL OF MEDICINE

Stent Thrombosis in Patients with Atrial Fibrillation Undergoing Coronary Stenting in the AUGUSTUS Trial

(2019) Renato D. Lopes et al.   CIRCULATION

Bleeding after antiplatelet therapy for the treatment of acute coronary syndromes: a review of the evidence and evolving paradigms

(2019) Sergio Buccheri et al.   Expert Opinion On Drug Safety

Ticagrelor in Patients with Stable Coronary Disease and Diabetes

(2019) P. Gabriel Steg et al.   NEW ENGLAND JOURNAL OF MEDICINE

Risk of gastrointestinal bleeding associated with oral anticoagulation and non-steroidal anti-inflammatory drugs in patients with atrial fibrillation: a nationwide study

(2019) Anne-Marie Schjerning Olsen et al.   European Heart Journal-Cardiovascular Pharmacotherapy

Intracranial haemorrhages vs. stent thromboses with direct oral anticoagulant plus single antiplatelet agent or triple antithrombotic therapy: a meta-analysis of randomized trials in atrial fibrillation and percutaneous coronary intervention/acute coronary syndrome patients

(2019) Mattia Galli et al.   EUROPACE

Switching Oral Anticoagulant Therapy in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention

(2019) Francesco Franchi et al.   JACC-Cardiovascular Interventions

Patients with atrial fibrillation and coronary artery disease – Double trouble

(2018) Ewelina Michniewicz et al.   Advances in Medical Sciences

Study of Two Dose Regimens of Ticagrelor Compared with Clopidogrel in Patients Undergoing Percutaneous Coronary Intervention for Stable Coronary Artery Disease (STEEL-PCI)

(2018) Rachel C. Orme et al.   CIRCULATION

The 2018 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation

(2018) Jan Steffel et al.   EUROPEAN HEART JOURNAL

Safety and efficacy of dual vs. triple antithrombotic therapy in patients with atrial fibrillation following percutaneous coronary intervention: a systematic review and meta-analysis of randomized clinical trials

(2018) Harsh B Golwala et al.   EUROPEAN HEART JOURNAL

Effect of Procedure and Coronary Lesion Characteristics on Clinical Outcomes Among Atrial Fibrillation Patients Undergoing Percutaneous Coronary Intervention

(2018) Mathieu Kerneis et al.   JACC-Cardiovascular Interventions

Cardiovascular Therapies Targeting Left Atrial Appendage

(2018) Mohit K. Turagam et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Aspirin-free strategies in cardiovascular disease and cardioembolic stroke prevention

(2018) Davide Capodanno et al.   Nature Reviews Cardiology

Evolution of Coronary Stent Technology and Implications for Duration of Dual Antiplatelet Therapy

(2018) Jae Youn Moon et al.   PROGRESS IN CARDIOVASCULAR DISEASES

Frequency and Outcomes of Reduced Dose Non–Vitamin K Antagonist Anticoagulants: Results From ORBIT‐AF II (The Outcomes Registry for Better Informed Treatment of Atrial Fibrillation II)

(2018) Benjamin A. Steinberg et al.   Journal of the American Heart Association

Antithrombotic Therapy in Patients With Atrial Fibrillation Treated With Oral Anticoagulation Undergoing Percutaneous Coronary Intervention

(2018) Dominick J. Angiolillo et al.   CIRCULATION

Vascular access and antithrombotic therapy in patients with acute coronary syndrome

(2018) Dominick J Angiolillo   LANCET

Association of Oral Anticoagulants and Proton Pump Inhibitor Cotherapy With Hospitalization for Upper Gastrointestinal Tract Bleeding

(2018) Wayne A. Ray et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

ACC/AHA Versus ESC Guidelines on Dual Antiplatelet Therapy

(2018) Davide Capodanno et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Cangrelor With and Without Glycoprotein IIb/IIIa Inhibitors in Patients Undergoing Percutaneous Coronary Intervention

(2017) Muthiah Vaduganathan et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Tailoring duration of DAPT with risk scores

(2017) Davide Capodanno et al.   LANCET

Derivation and validation of the predicting bleeding complications in patients undergoing stent implantation and subsequent dual antiplatelet therapy (PRECISE-DAPT) score: a pooled analysis of individual-patient datasets from clinical trials

(2017) Francesco Costa et al.   LANCET

Dual Antithrombotic Therapy with Dabigatran after PCI in Atrial Fibrillation

(2017) Christopher P. Cannon et al.   NEW ENGLAND JOURNAL OF MEDICINE

Antithrombotic Therapy in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention

(2016) Dominick J. Angiolillo et al.   Circulation-Cardiovascular Interventions

Radial Access Reduces Mortality in Patients With Acute Coronary Syndromes

(2016) Giuseppe Andò et al.   JACC-Cardiovascular Interventions

Efficacy and Safety of Dual Antiplatelet Therapy After Complex PCI

(2016) Gennaro Giustino et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Prevention of Bleeding in Patients with Atrial Fibrillation Undergoing PCI

(2016) C. Michael Gibson et al.   NEW ENGLAND JOURNAL OF MEDICINE

An open-label, randomized, controlled, multicenter study exploring two treatment strategies of rivaroxaban and a dose-adjusted oral vitamin k antagonist treatment strategy in subjects with atrial fibrillation who undergo percutaneous coronary intervention (PIONEER AF-PCI)

(2015) C. Michael Gibson et al.   AMERICAN HEART JOURNAL

Incidence, Predictors, and Impact of Post-Discharge Bleeding After Percutaneous Coronary Intervention

(2015) Philippe Généreux et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Oral anticoagulants for stroke prevention in atrial fibrillation: current status, special situations, and unmet needs

(2015) Freek W A Verheugt et al.   LANCET

Bivalirudin or Unfractionated Heparin in Acute Coronary Syndromes

(2015) Marco Valgimigli et al.   NEW ENGLAND JOURNAL OF MEDICINE

Polymer-free Drug-Coated Coronary Stents in Patients at High Bleeding Risk

(2015) Philip Urban et al.   NEW ENGLAND JOURNAL OF MEDICINE

Antiplatelet Therapy for Stable Coronary Artery Disease in Atrial Fibrillation Patients Taking an Oral Anticoagulant

(2014) Morten Lamberts et al.   CIRCULATION

Management of Antiplatelet and Anticoagulant Therapy in Patients With Atrial Fibrillation in the Setting of Acute Coronary Syndromes or Percutaneous Coronary Interventions

(2014) Davide Capodanno et al.   Circulation-Cardiovascular Interventions

Management of antithrombotic therapy in atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing percutaneous coronary or valve interventions: a joint consensus document of the European Society of Cardiology Working Group on Thrombosis, European Heart Rhythm Association (EHRA), European Association of Percutaneous Cardiovascular Interventions (EAPCI) and European Association of Acute Cardiac Care (ACCA) endorsed by the Heart Rhythm Society (HRS) and Asia-Pacific Heart Rhythm Society (APHRS)

(2014) et al.   EUROPEAN HEART JOURNAL

Novel antiplatelet agents in acute coronary syndrome

(2014) Francesco Franchi et al.   Nature Reviews Cardiology

Triple Therapy With Aspirin, Prasugrel, and Vitamin K Antagonists in Patients With Drug-Eluting Stent Implantation and an Indication for Oral Anticoagulation

(2013) Nikolaus Sarafoff et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Use of clopidogrel with or without aspirin in patients taking oral anticoagulant therapy and undergoing percutaneous coronary intervention: an open-label, randomised, controlled trial

(2013) Willem JM Dewilde et al.   LANCET

Effect of Platelet Inhibition with Cangrelor during PCI on Ischemic Events

(2013) Deepak L. Bhatt et al.   NEW ENGLAND JOURNAL OF MEDICINE

Antithrombotic Therapy in Patients With Atrial Fibrillation Undergoing Coronary Stenting

(2011) David P. Faxon et al.   Circulation-Cardiovascular Interventions

ACCF/SCAI/STS/AATS/AHA/ASNC 2009 Appropriateness Criteria for Coronary Revascularization

(2009) et al.   CIRCULATION

Rivaroxaban versus placebo in patients with acute coronary syndromes (ATLAS ACS-TIMI 46): a randomised, double-blind, phase II trial

(2009) JL Mega et al.   LANCET

Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes

(2009) Lars Wallentin et al.   NEW ENGLAND JOURNAL OF MEDICINE

Long-Term Outcomes in Patients Undergoing Coronary Stenting on Dual Oral Antiplatelet Treatment Requiring Oral Anticoagulant Therapy

(2008) Roberta Rossini et al.   AMERICAN JOURNAL OF CARDIOLOGY

Bivalirudin during Primary PCI in Acute Myocardial Infarction

(2008) Gregg W. Stone et al.   NEW ENGLAND JOURNAL OF MEDICINE